LNTH Q4 2020 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

Q4 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$94M+5.4% YoY

Gross Profit

$39M41.1% margin

Operating Income

-$528,000-0.6% margin

Net Income

-$3M-3.6% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

+6.3%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$2M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$870M

Total Liabilities

$356M

Stockholders' Equity

$514M

Cash & Equivalents

$80M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$94M	$89M	+5.4%
Gross Profit	$39M	$45M	-13.3%
Operating Income	-$528,000	$12M	-104.2%
Net Income	-$3M	$10M	-132.7%

Revenue Segments

US Segment

$160M87%

International Segment

$25M13%